BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Active Pass Pharmaceuticals Announces Promotion Of David MacDonald To President And Chief Operating Officer


10/19/2005 5:09:39 PM

VANCOUVER, British Columbia--(BUSINESS WIRE)--Jan. 9, 2004--Active Pass announces the promotion of Dr. David MacDonald to the position of President & Chief Operating Officer. Concomitant with the appointment, Dr. MacDonald joins the Company's Board of Directors. Commenting on the appointment, Chief Executive Officer Dr. Peter B. Reiner stated, "It is a rare privilege to have someone of David's talents within the organization. His contributions to the business have been exemplary, and we are delighted to have him take on these additional responsibilities as the Company continues its transition from discovery to development."

David MacDonald, Ph.D. has over 15 years of experience at pharmaceutical and biotechnology firms, including a wide range of critical activities within the drug discovery and development process. Dr. MacDonald joined Active Pass in September 2001 as Vice President, Research and Development. Previously, he was General Manager of Biovail Contract Research, as well as having held positions of increasing responsibility at Syntex and Hemosol. Dr. MacDonald obtained his Ph.D. in Chemistry from the University of Alberta, where his research was focused on enzymology and enzyme kinetics.

About Active Pass

Active Pass is a privately held biotechnology company developing drugs that target ABC transporters, a valuable class of targets for diseases with substantial markets. Our gene-family approach to drug discovery enables us to profile compounds for potency, specificity and bioavailability, identifying those compounds most likely to survive the rigors of drug development. Moreover, our balanced portfolio of therapeutic programs, including secretory diarrhea, age-related macular degeneration, and lipid disorders, provides multiple opportunities for success.

Contacts

Active Pass Pharmaceuticals, Vancouver
Peter B. Reiner, 604-879-2775
Fax: 604-879-2707
info@activepass.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES